Skip to main content
Log in

Mechanistic insights into ceramidase inhibitor LCL521-enhanced tumor cell killing by photodynamic and thermal ablation therapies

  • Paper
  • Published:
Photochemical & Photobiological Sciences Aims and scope Submit manuscript

Abstract

Our recent investigation uncovered that the acid ceramidase inhibitor LCL521 enhances the direct tumor cell killing effect of photodynamic therapy (PDT) treatment. The present study aimed at elucidating the mechanisms underlying this effect. Exposing mouse squamous cell carcinoma SCCVII cells treated with temoporfin-based PDT to LCL521 (rising ceramide concentration) produced a much greater decrease in cell survival than comparable exposure to the sphingosine kinase-1 inhibitor PF543 (that reduces sphingo-sine-1-phosphate concentration). This is consistent with recognizing the rising levels of pro-apoptotic sphingolipid ceramide as being more critical in promoting the death of PDT-treated cells than the reduction in the availability of pro-survival acting sphingosine-1 phosphate. This pro-apoptotic impact of LCL521, which was suppressed by the apoptosis inhibitor bongkrekic acid, involves the interaction with the cellular stress signaling network. Hence, inhibiting the key elements of these pathways markedly influenced the adjuvant effect of LCL521 on the PDT response. Particularly effective was the inositol-requiring element-1 (IRE1) kinase inhibitor STF-083010 that dramatically enhanced the killing of cells treated with PDT plus LCL521. An important role in the survival of these cells was exhibited by master transcription factors STAT3 and HIF-1α. The STAT3 inhibitor NSC 74859 was especially effective in further reducing the cell survival rates, suggesting its possible exploitation for therapeutic gain. An additional finding in this study is that LCL521-promoted PDT-mediated cell killing through ceramide-mediated lethal effects is extended to the interaction with other cancer treatment modalities with a rapid cellular stress impact such as photothermal therapy (PTT) and cryoablation therapy (CAT).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. P. Agostinis, K. Berg, K. A. Cengel, T. H. Foster, A. W. Girotti, S. O. Gollnick, S. M. Hahn, M. R. Hamblin, A. Juzeniene, D. Kessel, M. Korbelik, J. Moan, P. Mroz, D. Nowis, J. Piette, B. C. Wilson and J. Golab, Photodynamic therapy of cancer: an update, CA Cancer J. Clin., 2011, 61, 250–281.

    Article  Google Scholar 

  2. T. J. Dougherty, C. J. Gomer, B. W. Henderson, G. Jori, D. Kessel, M. Korbelik, J. Moan and Q. Peng, J. Natl. Cancer Inst., 1998, 90, 889–905.

    Article  CAS  Google Scholar 

  3. M. Korbelik, Role of cell stress signaling networks in cancer cell death and antitumor immune response following proteotoxic injury inflicted by photodynamic therapy, Lasers Surg. Med., 2018, 50, 491–498.

    Article  Google Scholar 

  4. I. B. Hernandez, Y. Yu, F. A. Ossendorp, M. Korbelik and S. Oliviera, The immune response triggered in oncologic photodynamic therapy: clinical recommendations, J. Clin. Med., 2020, 9(2), 333, DOI: 10.3390/jcm9020333.

  5. M. Korbelik, J. Banáth, W. Zhang, P. Gallagher, T. Hode, S. S. K. Lam and W. R. Chen, N-dihydrogalactochitosan as immune and direct antitumor agent amplifying the effects of photodynamic therapy and photodynamic therapy-generated vaccines, Int. Immunopharmacol., 2019, 75, 105764.

    Article  CAS  Google Scholar 

  6. M. Korbelik, J. Banath, W. Zhang, K. M. Saw, Z. M. Szulc, A. Bielawska and D. Separovic, Interaction of acid ceramidase inhibitor LCL521 with tumor response to photodynamic therapy and related vaccine, Int. J. Cancer, 2016, 139, 1372–1378.

    Article  CAS  Google Scholar 

  7. M. Korbelik, Sphingolipid activity in oxidative stress response and tumor immunity, Austin J. Vaccines Immunother., 2016, 3(1), 1008.

    Google Scholar 

  8. F. Liu, X. Li, C. Lu, A. Bai, J. Bielawski, B. Marshall, P. V. Schoenlein, I. O. Kebedyeva and K. Liu, Ceramide activates lysosomal cathepsin B and cathepsin D to attenuate autophagy and induces ER stress to suppress myeloid-derived suppressor cells, Oncotarget, 2016, 7, 83907–83925.

    Article  Google Scholar 

  9. D. Separovic, J. Bielawski, J. S. Pierce, A. L. Tarca, B. Ogretmen and M. Korbelik, Increased tumour dihydro-ceramide production after Photofrin-PDT alone and improved tumour response after the combination with the ceramide analogue LCL29. Evidence from mouse squamous cell carcinoma, Br. J. Cancer, 2009, 100, 626–632.

    Article  CAS  Google Scholar 

  10. M. Korbelik, W. Zhang, K. M. Saw, Z. M. Szulc, A. Bielawska and D. Separovic, Cationic ceramides and analogues, LCL30 and LCL85, as adjuvants to photodynamic therapy of tumors, J. Photochem. Photobiol., B, 2013, 126, 72–77.

    Article  CAS  Google Scholar 

  11. D. Separovic, P. Breen, N. B. Boppana, E. van Buren, N. Joseph, J. M. Kraveka, M. Rahmaniyan, L. Li, T. I. Gudz, A. Bielawska, A. Bai, J. Bielawski, J. S. Pierce and M. Korbelik, Increased killing of SCCVII squamous cell carcinoma cells after the combination of Pc 4 photodynamic therapy and dasatinib is associated with enhanced caspase-3 activity and ceramide synthase 1 upregulation, Int. J. Oncol., 2013, 43, 2064–2072.

    Article  CAS  Google Scholar 

  12. T. Yabu, H. Shiba, Y. Shibasaki, T. Nakanishi, S. Imamura, K. Touhata and M. Yamashita, Stress-induced ceramide generation and apoptosis via the phosphorylation and activation of nSMase by JNK signalling, Cell Death Differ., 2015, 22, 258–273.

    Article  CAS  Google Scholar 

  13. R. Nganga, N. Oleinik and B. Ogretmen, Mechanisms of ceramide-dependent cancer cell death, Adv. Cancer Res., 2018, 140, 1–25.

    Article  CAS  Google Scholar 

  14. D. Khurana, E. A. Martin, J. L. Kasperbauer, B. W. O’Malley, D. R. Salomao, L. Chen and S. E. Strome, Characterization of a spontaneously arising murine squamous cell carcinoma (SCC VII) as a prerequisite for head and neck cancer immunotherapy, Head Neck, 2001, 23, 899–906.

    Article  CAS  Google Scholar 

  15. A. Bai, Z. M. Szulc, J. Bielawski, J. S. Pierce, B. Rembiesa, S. Terzieva, C. Mao, R. Xu, B. Wu, C. J. Clarke, B. Newcomb, X. Liu, J. Norris, Y. S. Hannun and A. Bielawska, Targeting (cellular) lysosomal acid ceramidase by B13: Design, synthesis and evaluation of novel DMG-B13 ester prodrugs, Bioorg. Med. Chem., 2014, 22, 6933–6944.

    Article  CAS  Google Scholar 

  16. M. Korbelik, J. Banáth, W. Zhang, T. Hode, S. S. K. Lam, P. Gallagher, J. Zhao, H. Zeng and W. R. Chen, N-dihydro-galactochitosan-supported tumor control by photothermal therapy and photothermal therapy-generated vaccine, J. Photochem. Photobiol., B, 2020, 204, 111780.

    Article  CAS  Google Scholar 

  17. Y. A. Hannun and L. M. Obeid, Principles of bioactive lipid signaling: lessons from sphingolipids, Nat. Rev. Mol. Cell Biol., 2008, 9, 139–150.

    Article  CAS  Google Scholar 

  18. D. Shida, K. Takabe, D. Kapitanov, S. Milstein and S. Spiegel, Targeting SphK1 as a new strategy against cancer, Curr. Drug Targets, 2008, 9, 662–673.

    Article  CAS  Google Scholar 

  19. J. C. Cheng, A. Bai, T. H. Beckham, S. T. Marrison, C. L. Yount, K. Young, P. Lu, A. M. Bartlett, B. X. Wu, B. J. Keane, K. E. Armeson, D. T. Marshall, T. E. Keane, M. T. Smith, E. E. Jones, R. R. Drake Jr., A. Bielawska, J. S. Norris and X. Liu, Radiation-induced acid ceramidase confers prostate cancer resistance and tumor relapse, J. Clin. Invest, 2013, 123, 4344–4358.

    Article  CAS  Google Scholar 

  20. M. E. Schnute, M. D. McReynolds, T. Kasten, M. Yates, G. Jerome, J. W. Rains, T. Hall, J. Chrenick, M. Kraus, C. N. Cronin, M. Saabye, M. K. Highkin, R. Broadus, S. Oqawa, K. Cukyne, L. E. Zawadzke, V. Peterkin, K. Ivanar, J. A. Scholten, J. Wendling, H. Fujiwara, O. Nemirovskiy, A. J. Wittwer and M. M. Nagiec, Modulation of cellular S1P levels with a novel, potent and specific inhibitor of sphin-gosine kinase-1, Biochem. J., 2012, 444(1), 79–88.

    Article  CAS  Google Scholar 

  21. N. B. Bopanna, U. Stochaj, M. Kodiha, A. Bielawska, J. Bielawski, J. S. Price, M. Korbelik and D. Separovic, C6-pyridinium ceramide sensitizes SCC17B human head and neck squamous cell carcinoma cells to photodynamic therapy, J. Photochem. Photobiol., B, 2015, 143, 163–168.

    Article  Google Scholar 

  22. K. Dodo, M. Katoh, T. Shimizu, M. Takahashi and M. Sodeoka, Inhibition of hydrogen peroxide-induced necrotic cell death with 3-amino-2-indoIyImaIeimide derivatives, Bioorg. Med. Chem. Lett., 2005, 15, 3114–3118.

    Article  CAS  Google Scholar 

  23. H. S. Yoon, S. C. Moon, N. D. Kim, B. S. Park, M. H. Jeong and Y. H. Yoo, Geinstein induces apoptosis of RPE-J cells by opening mitochondrial PTP, Biochem. Biophys. Res. Commun., 2000, 276, 151–156.

    Article  CAS  Google Scholar 

  24. I. Papandreu, N. C. Denko, M. Olson, H. Van Melckebeke, S. Lust, A. Tam, D. E. Solow-Cordero, D. M. Bouley, F. Offner, M. Niwa and A. C. Koong, Identification of an IRE1alpha endonuclease specific inhibitor with cytotoxic activity against human multiple myeloma, Blood, 2011, 117, 1311–1314.

    Article  Google Scholar 

  25. H. P. Harding, A. F. Zyryanova and D. Ron, Uncoupling proteostasis and development in vitro with a small molecule inhibitor of pancreatic endoplasmic reticulum kinase, PERK, J. Biol. Chem., 2012, 287, 44338–44344.

  26. C. Sidrauski, D. Acosta-Alvear, A. Khoutorsky, P. Vedantham, B. R. Hearn, K. Gamache, C. M. Gallagher, K. K. Ang, C. Wlison, V. Okreglak, A. Ashkenazi, B. Hann, K. Nader, M. R. Arkin, A. R. Benslo, N. Sonenberg and P. Walter, Pharmacological brake-release of mRNA translation enhances cognitive memory, eLife, 2013, e00498.

  27. B. G. Hoffstrom, A. Kaplan, R. Letso, R. S. Schmid, G. J. Turmel, D. C. Lo and B. R. Stockwell, Inhibitors of protein disulfide isomerase suppress apoptosis induced by misfolded proteins, Nat. Chem. Biol., 2010, 6, 900–906.

  28. C. Grek and D. M. Townsend, Protein disulfide isomerase superfamily in disease and regulation of apoptosis, Endoplasmic Reticulum Stress Dis., 2014, 1, 4–17.

  29. M. Pajares, A. Cuadrado and A. I. Rojo, Modulation of proteasis by transcription factor NRF2 and impact in neurode-generative diseases, Redox Biol., 2017, 11, 543–553.

  30. A. Batista, J. J. Rodvold, S. Xian, S. C. Searles, A. Lew, T. Iwawaki, G. Almanza, T. C. Waller, J. Lin, K. Jepsen, H. Carter and M. Zanetti, IRE1α regulates macrophage polarization, PD-L1 expression, and tumor survival, PLoS Biol., 2020, 8(6), e3000687.

  31. J. Li, Y.-Q. Yuan, L. Zhang, H. Zhang, S.-W. Zhang, Y. Zhang, X.-X. Xuan, M.-J. Wang and J.-Y. Zhang, Exogenous hydrogen sulfide protect against high glucose-induced apoptosis and oxidative stress by inhibiting the STAT3/HIF-1α pathway in H9c2 cardiomiocytes, Exp. Ther. Med., 2019, 18, 3948–3958.

  32. L. Qiao, C. Xu, Q. Li, Z. Mei, X. Li, H. Cai and W. Liu, Photodynamic therapy activated STAT3 associated pathways: Targeting intrinsic apoptotic pathways to increase PDT efficacy in human squamous carcinoma cells, Photodiagn. Photodyn. Ther., 2016, 14, 119–127.

  33. S. Mitra, S. E. Cassar, D. J. Niles, J. A. Puskas, J. G. Frelinger and T. H. Foster, Photodynamic therapy mediates the oxygen-dependent activation of hypoxia-inducible factor 1α, Mol. Cancer Ther., 2006, 5, 3268–3274.

  34. K. Siddiquee, S. Zhang, W. C. Guida, M. A. Blaskovich, B. Greedy, H. R. Lawrence, M. L. Yip, R. Jove, M. M. McLaughlin, N. J. Lawrence, S. M. Sebti and J. Turkson, Selective chemical probe inhibitor of Stat3, identified through structure-based virtual screening, induces antitumor activity, Proc. Natl. Acad. Sci. U. S. A., 2007, 104, 7391–7396.

    Article  CAS  Google Scholar 

  35. K. Lee, J. E. Kang, S.-K. Park, Y. Jin, K.-S. Chung, H.-M. Kim, K. Lee, M. R. Kang, M. K. Lee, K. B. Song, E.-G. Yang, J.-J. Lee and M. Won, LW6, a novel Hif-1 inhibitor, promotes proteosomal degradation of HIF-1α via upre-gulation of VHL in as colon cancer cell line, Biochem. Pharmacol., 2010, 80, 982–989.

  36. F. Zhou, X. Li, M. F. Naylor, T. Hode, R. E. Nordquist, L. Alleruzzo, J. Baker, S. S. K. Lam, N. Du, L. Shi, X. Wang and W. R. Chen, InCVAX –a novel strategy for treatment of late-stage metastatic cancers through photoimmunotherapy induced tumor-specific immunity, Cancer Lett., 2015, 359, 169–177.

  37. R. I. Cazzato, J. Garnon, N. Ramamurthy, G. Koch, G. Tsoumakidou, J. Caudrelier, F. Argioni, L. Zugaro, A. Barile, C. Masciocchi and A. Gang, Percutaneous image-guided cryoablation: current applications and results in oncologic field, Med. Oncol., 2016, 33, 140.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mladen Korbelik.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Korbelik, M., Zhao, J., Zeng, H. et al. Mechanistic insights into ceramidase inhibitor LCL521-enhanced tumor cell killing by photodynamic and thermal ablation therapies. Photochem Photobiol Sci 19, 1145–1151 (2020). https://doi.org/10.1039/d0pp00116c

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1039/d0pp00116c

Navigation